BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.27M | 9.84M | 10.98M | 9.86M | 11.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.27M | 9.84M | 10.98M | 9.86M | 11.67M |
| Cost of Revenue | 4.91M | 9.73M | 9.97M | 8.98M | 5.59M |
| Gross Profit | 4.36M | 110.00K | 1.01M | 875.60K | 6.08M |
| SG&A Expenses | 6.66M | 1.35M | 1.42M | 1.39M | 6.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.57M | 11.08M | 11.39M | 10.37M | 11.79M |
| Operating Income | -2.30M | -1.24M | -410.30K | -518.80K | -118.20K |
| Income Before Tax | -2.15M | -1.04M | -189.50K | -343.40K | 26.30K |
| Income Tax Expenses | 884.80K | -285.50K | -52.20K | -94.60K | 123.00K |
| Earnings from Continuing Operations | -3.03M | -752.50K | -137.30K | -248.80K | -96.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.03M | -752.50K | -137.30K | -248.80K | -96.70K |
| EBIT | -2.30M | -1.24M | -410.30K | -518.80K | -118.20K |
| EBITDA | -1.77M | -692.10K | 156.70K | 47.50K | 447.60K |
| EPS Basic | -3.39 | -0.84 | -0.15 | -0.28 | -0.11 |
| Normalized Basic EPS | -1.50 | -0.73 | -0.13 | -0.24 | 0.02 |
| EPS Diluted | -3.39 | -0.84 | -0.15 | -0.28 | -0.11 |
| Normalized Diluted EPS | -1.50 | -0.73 | -0.13 | -0.24 | 0.02 |
| Average Basic Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Average Diluted Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Dividend Per Share | -- | -- | -- | -- | 0.50 |
| Payout Ratio | -- | -- | -- | -- | 0.00% |